Healthscope Limited (HSP) will go ex dividend on 27/9/2010. The current dividend payment is 12 cents and it is 100% franked. The record date is 1/10/2010 and the dividend will be paid on 4/10/2010. Based on the full year payment the dividend yield is 3.8%.
*Current Yield: 2.0% Franking: 100% DRP Discount: 2.5%
*Yield has been calculated on the closing price on the 13/9/2010. Current yield is based on the current dividend payment only.
Healthscope (HSP) announced on the 26/8/2009 that they would be conducting a Share Purchase Plan to raise additional capital. The record date was the 28/8/2009 on which shareholders must own the share to participate in the SPP. The closing date is 1/10/2009. Shares will be issued on 9/10/2009 and begin trading on 13/10/2009. A maximum of $15,000 can be purchased by each shareholder at $4.19.
Discount : 8.3% Liquidity : Good Profitability : Good Stability : Good
* Note: Discount is based on the closing price on the 10 September 2009.
For More Share Purchase Plans go to http://blog.mdsfinancial.com.au/category/share-purchase-plans/
To Buy Shares And Participate in Share Purchase Plans use Trader Dealer http://www.traderdealer.com.au/
Last night Circadian Technologies signed a $10 million deal with private hospital operator Healthscope to test and market a breakthrough cancer diagnostic tool. The technology, which helps identify the source of secondary cancers, will be commercially available within months.
On top of this impressive news, Circadian said it expected to make several more announcements of a similar nature this year.
Amid all the bad results being reported recently, Circadian s half-year results showed cash reserves of $42.1 million.
Healthscope, meanwhile, posted a 145% rise in first half profit, and a 13.9% increase in revenue, lending weight to the theory that the biotech and health care sectors traditionally weather economic adversity fairly well.
Back in October, biotech expert David Langsam analysed several stocks and identified many investment opportunities. Click here to read the article
Stocks for your watch list:
Further information:
